Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04625088Completed
Open-label trial (2 arms), sponsored by SciMar. Primary endpoints: Time course change in serum glucose, Time course change in serum insulin and 2 more. Started Mar 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04625088.